Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Komal S Rathi

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Cell Reports. Medicine|August 2, 2021
A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitopeSwetha Raman, Samantha N Buongervino, Maria V Lane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2019
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALLKathryn Evans, JianXin Duan, Tara Pritchard, et al.
Cell Reports|March 31, 2021
Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modalityMai T Dang, Michael V Gonzalez, Krutika S Gaonkar, et al.
International Forum of Allergy & Rhinology|September 12, 2021
Targeted gene expression profiling of inverted papilloma and squamous cell carcinomaCharles C L Tong, Mateusz Koptyra, Pichai Raman, et al.
AJNR. American Journal of Neuroradiology|February 14, 2025
Imaging Clusters of Pediatric Low-Grade Glioma are Associated with Distinct Molecular CharacteristicsAnahita Fathi Kazerooni, Adam Kraya, Komal S Rathi, et al.
Cancer Cell|September 13, 2017
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk NeuroblastomaKristopher R Bosse, Pichai Raman, Zhongyu Zhu, et al.
Nature Communications|January 2, 2025
Multiparametric MRI along with machine learning predicts prognosis and treatment response in pediatric low-grade gliomaAnahita Fathi Kazerooni, Adam Kraya, Komal S Rathi, et al.
Biorxiv : the Preprint Server for Biology|August 16, 2024
Characterization of aberrant splicing in pediatric central nervous system tumors reveals <i>CLK1</i> as a candidate oncogenic dependencyAmmar S Naqvi, Ryan J Corbett, Priyanka Seghal, et al.
Cancer Research|February 19, 2021
GAS7 Deficiency Promotes Metastasis in MYCN-Driven NeuroblastomaZhiwei Dong, Kok Siong Yeo, Gonzalo Lopez, et al.
Cancer Discovery|September 23, 2021
<i>MYC</i> Levels Regulate Metastatic Heterogeneity in Pancreatic AdenocarcinomaRavikanth Maddipati, Robert J Norgard, Timour Baslan, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Cell Reports. Medicine|August 2, 2021
A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitopeSwetha Raman, Samantha N Buongervino, Maria V Lane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2019
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALLKathryn Evans, JianXin Duan, Tara Pritchard, et al.
Cell Reports|March 31, 2021
Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modalityMai T Dang, Michael V Gonzalez, Krutika S Gaonkar, et al.
International Forum of Allergy & Rhinology|September 12, 2021
Targeted gene expression profiling of inverted papilloma and squamous cell carcinomaCharles C L Tong, Mateusz Koptyra, Pichai Raman, et al.
AJNR. American Journal of Neuroradiology|February 14, 2025
Imaging Clusters of Pediatric Low-Grade Glioma are Associated with Distinct Molecular CharacteristicsAnahita Fathi Kazerooni, Adam Kraya, Komal S Rathi, et al.
Cancer Cell|September 13, 2017
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk NeuroblastomaKristopher R Bosse, Pichai Raman, Zhongyu Zhu, et al.
Nature Communications|January 2, 2025
Multiparametric MRI along with machine learning predicts prognosis and treatment response in pediatric low-grade gliomaAnahita Fathi Kazerooni, Adam Kraya, Komal S Rathi, et al.
Biorxiv : the Preprint Server for Biology|August 16, 2024
Characterization of aberrant splicing in pediatric central nervous system tumors reveals <i>CLK1</i> as a candidate oncogenic dependencyAmmar S Naqvi, Ryan J Corbett, Priyanka Seghal, et al.
Cancer Research|February 19, 2021
GAS7 Deficiency Promotes Metastasis in MYCN-Driven NeuroblastomaZhiwei Dong, Kok Siong Yeo, Gonzalo Lopez, et al.
Cancer Discovery|September 23, 2021
<i>MYC</i> Levels Regulate Metastatic Heterogeneity in Pancreatic AdenocarcinomaRavikanth Maddipati, Robert J Norgard, Timour Baslan, et al.
Pageof 4